Screener/Healthcare/Biotechnology

NAMS

NewAmsterdam Pharma Company N.V.NASDAQ
$29.96+0.01 (+0.03%)
Mid CapUnder $50HealthcareLow Beta
$14.06
$42.00
$28.98
$30.66
EPS (TTM)$-1.73
P/E Ratio—
Dividend Yield—
Market Cap$3.45B
Volume493K
Prev Close$30.01
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$32K-$74.9M$-0.63—-234134.4%
Q3 '25$348K-$72.0M$-0.61—-20691.1%
Q2 '25$19.1M-$17.4M$-0.15—-90.7%
Q1 '25$3.0M-$39.5M$-0.34—-1327.3%
Q4 '24$12.8M-$92.2M$-0.95—-721.7%
Q3 '24$29.1M-$16.6M$-0.18—-57.2%
Q2 '24$2.3M-$39.0M$-0.41100.0%-1711.6%
Q1 '24$1.4M-$93.8M$-1.06—-6692.9%
Get Your Daily Market Recap